Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02993965 · ClinicalTrials.gov registry record · NA

State Immunization Information Systems to Improve HPV Vaccination Rates

A NA study of Reproductive Health and Preventive Health Services, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
77,716
Enrollment target
1
Study location

NCT02993965 is a NA study of Reproductive Health and Preventive Health Services that has completed, run by University of Colorado, Denver. The registered enrollment target is 77,716 participants, above the 50,590-participant average among 10 other Reproductive Health trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02993965, a NA study of Reproductive Health and Preventive Health Services, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
77,716 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17 (with a more focused look at the new two dose series for 11-14 year olds).

Interventions

  • OTHER Vaccine Reminder/Recall

Study Locations (1)

Colorado

  • University of Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 77,716 participants
Start Date 2017-02-21
Est. Completion 2020-07-31
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02993965

The ClinicalTrials.gov registry entry for NCT02993965 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77,716 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 50,590-participant average among 10 other Reproductive Health trials with a reported enrollment target (54% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Reproductive Health appearing as the primary indexed condition, and to 1 intervention - of which Vaccine Reminder/Recall is the first listed.

NCT02993965 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02993965 about?

NCT02993965 is a clinical study titled "State Immunization Information Systems to Improve HPV Vaccination Rates". The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17 (...

What is the current status of trial NCT02993965?

This trial is currently completed. It is a NA study. The enrollment target is 77,716 participants. The study started on 2017-02-21. Estimated completion is 2020-07-31.

What conditions does trial NCT02993965 study?

This clinical trial studies the following conditions: Reproductive Health, Preventive Health Services, Vaccine, Immunization, Adolescent Health.

What interventions are being tested in trial NCT02993965?

The interventions under investigation include: Vaccine Reminder/Recall (OTHER).

Who is sponsoring clinical trial NCT02993965?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02993965 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Reproductive Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.